Andrew Gengos, See Below at Athira Pharma, Inc. (ATHA), bought 55,012 shares at $2.75 ($162K) on 2023-06-02, disclosed to the SEC on 2023-06-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.75 | 10,012 | $28K | 17.0% |
| 2 | $2.86 | 6,582 | $19K | 11.6% |
| 3 | $2.95 | 3,418 | $10K | 6.2% |
| 4 | $3.00 | 10,000 | $30K | 18.6% |
| 5 | $3.00 | 15,000 | $45K | 27.8% |
| 6 | $3.02 | 10,000 |
| $30K |
| 18.7% |
| Total | $2.94 avg | 55,012 | $162K | 100% |
| Filing → |
| ATHA | SELL | 2024-09-05 | $725 | — | Filing → |
| ATHA | SELL | 2024-02-16 | $4K | — | Filing → |
| ATHA | SELL | 2024-01-08 | $4K | — | Filing → |